Clinical trial
Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With…
NCT00086970 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00086970 |
|---|---|
| Title | Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors |
| Official title | A Phase I Study Of BG In Combination With Ifosfamide For Advanced Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | ifosfamide, O6-benzylguanine |
| Enrollment | 32 |
| Start date | Jun 1, 2004 |
| Primary completion | Nov 1, 2005 |
| First posted | Jul 12, 2004 |
| Last update posted | Jan 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: